The sodium-glucose cotransporter-2 (SGLT2) inhibitors synergize with nitric oxide and prostacyclin to reduce human platelet activation
Caroline Honaiser Lescano, Guilherme Ruiz Leonardi, Pedro Henrique Portugal Torres, Tiago Nardi Amaral, Luiz Henrique de Freitas Filho, Edson Antunes, Cristina Pontes Vicente, Gabriel Forato Anhê, Fabíola Z. Mónica
Topics & Concepts
ProstacyclinChemistrySodium nitroprussideNitric oxidePlatelet activationEndocrinologyPharmacologyInternal medicineThromboxaneDapagliflozinPlateletBiochemistryMedicineDiabetes mellitusType 2 diabetesDiabetes Treatment and ManagementPlatelet Disorders and TreatmentsChronic Lymphocytic Leukemia Research